Cargando…
Glutamine synthetase mediates sorafenib sensitivity in β-catenin-active hepatocellular carcinoma cells
The gene encoding β-catenin is frequently mutated in hepatocellular carcinoma cells. While the oncogenicity of β-catenin has been extensively studied, β-catenin’s role in hepatocellular carcinoma tumor metabolism is currently less well understood. In this study, we found that β-catenin regulates the...
Autores principales: | Sohn, Bo Hwa, Park, In Young, Shin, Ji-Hyun, Yim, Sun Young, Lee, Ju-Seog |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992988/ https://www.ncbi.nlm.nih.gov/pubmed/29303508 http://dx.doi.org/10.1038/emm.2017.174 |
Ejemplares similares
-
Correlation of Exon 3 β-catenin Mutations with Glutamine Synthetase Staining Patterns in Hepatocellular Adenoma and Hepatocellular Carcinoma
por: Hale, Gillian, et al.
Publicado: (2016) -
Glutamine synthetase-negative hepatocellular carcinoma has better prognosis and response to sorafenib treatment after hepatectomy
por: Shao, Mingyang, et al.
Publicado: (2023) -
Structural Analysis of Glutamine Synthetase from Helicobacter pylori
por: Joo, Hyun Kyu, et al.
Publicado: (2018) -
Glutamine synthetase: a tumor suppressor in hepatocellular carcinoma?
por: Dai, Weiwei, et al.
Publicado: (2023) -
Glutamine Synthetase as a Therapeutic Target for Cancer Treatment
por: Kim, Go Woon, et al.
Publicado: (2021)